FDA-Drug2018-11-14Class III
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99
Orexigen Therapeutics, Inc.
Hazard
Container packaging defect.
Sold states
Within the United States
Affected count
18,895 bottles
Manufactured in
3344 N Torrey Pines Ct Ste 200, La Jolla, CA, United States
Products
Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90 mg, 120-count bottles, Rx only, Distributed by Orexigen therapeutics, Inc., La Jolla, CA 92037, NDC 51267-890-99
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0219-2019Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief